intranasal glutathione in parkinson& 39 Central nervous system uptake of Parkinson's disease Revamping Parkinson's disease therapy using
Revamping Parkinson's disease therapy using PLGA based drug delivery systems npj Parkinson's Disease Frontiers Neuroinflammation in Parkinson's Disease Putative Pathomechanisms and Targets for Disease Modification Intranasal Delivery of Metabolically Resilient Glutathione: In Vivo Pharmacokinetic, Permeation, and Efficacy Studies Molecular Pharmaceutics Research progress on intranasal treatment for Parkinson's disease Wen 2024 Neuroprotection Wiley Online Library Unlocking the potential of lipid based nanoparticles for intranasal drug delivery in Parkinson's disease ScienceDirect
Pay in 4 interest-free payments of $5.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




